Study supports less-invasive Barrett’s treatment

Endoluminal therapy effectively treats patients with Barrett’s esophagus and high-grade dysplasia or intramucosal carcinoma, according to researchers from the University of Pennsylvania Perelman School of Medicine. Esophagectomy is the standard treatment, but researchers noted that endoluminal therapy, which uses endoscopic mucosal resection and ablation, is less invasive than surgery. Medscape (free registration) (2/15)